MedPath

Comparison of the effect of rectal Misoprostol and Syntometrin in prevention of post partum hemorrhage

Not Applicable
Conditions
Post partum hemorrhage.
Postpartum care and examination
Registration Number
IRCT201008212854N5
Lead Sponsor
Vice chancellor for Basic Sciences, Kashan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
200
Inclusion Criteria

pregnant women with single pregnancy and candidate for vaginal delivery Exclusion criteria: Presence of preeclampsia, hypotension, heart disease, asthma, hypertonic uterus, uterine rupture, or vaginal and cervical laceration, being high risk for postpartum bleeding such as: multiparity, uterine myoma, history of postpartum bleeding, or need for uterine curettag

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
terine tone. Timepoint: 0.5 and 1 hours after delivery. Method of measurement: Assessment of uterine tone.;Hemoglobin level. Timepoint: Before and 24 hours after delivery. Method of measurement: Hemoglobine assessment.;Blood Pressure. Timepoint: immadiate, 30 minute and 1 hour after delivery. Method of measurement: by sphygnomanometer.;Pulse. Timepoint: immadiately, 30 minute and 1 hours after delivery. Method of measurement: by counting.
Secondary Outcome Measures
NameTimeMethod
Adverse effects. Timepoint: During Hospitalization. Method of measurement: Observation of adverse effects.;Need to adminestration of utertonic drug. Timepoint: During 24 hours after delivery. Method of measurement: dosage and amount of drug.
© Copyright 2025. All Rights Reserved by MedPath